Jessica Hope Roark

Array ( [id] => 6134988 [patent_doc_number] => 20110008802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'TNFalpha GENE EXPRESSION AS A BIOMARKER OF SENSITIVITY TO ANTAGONISTS OF INHIBITOR OF APOPTOSIS PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/598940 [patent_app_country] => US [patent_app_date] => 2008-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5114 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20110008802.pdf [firstpage_image] =>[orig_patent_app_number] => 12598940 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046607 [patent_doc_number] => 20110206657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'ANTIBODIES BINDING TO AN INTRACELLULAR PRL-1 OR PRL-3 POLYPEPTIDE' [patent_app_type] => utility [patent_app_number] => 12/598442 [patent_app_country] => US [patent_app_date] => 2008-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 36789 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20110206657.pdf [firstpage_image] =>[orig_patent_app_number] => 12598442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927370 [patent_doc_number] => 20080166733 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'METHOD FOR DETERMINING THE PROGNOSIS OF CANCER PATIENTS BY MEASURING LEVELS OF BAG EXPRESSION' [patent_app_type] => utility [patent_app_number] => 12/052693 [patent_app_country] => US [patent_app_date] => 2008-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10934 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166733.pdf [firstpage_image] =>[orig_patent_app_number] => 12052693 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4955388 [patent_doc_number] => 20080188412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Bcl-2 promoted cell death' [patent_app_type] => utility [patent_app_number] => 12/002844 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 30 [patent_no_of_words] => 7345 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20080188412.pdf [firstpage_image] =>[orig_patent_app_number] => 12002844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4859099 [patent_doc_number] => 20080267949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Peptides capable of binding to serum proteins' [patent_app_type] => utility [patent_app_number] => 11/999497 [patent_app_country] => US [patent_app_date] => 2007-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 31735 [patent_no_of_claims] => 157 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0267/20080267949.pdf [firstpage_image] =>[orig_patent_app_number] => 11999497 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9355527 [patent_doc_number] => 08674060 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-03-18 [patent_title] => 'Peptide ligand to impair cancer cell migration' [patent_app_type] => utility [patent_app_number] => 11/946303 [patent_app_country] => US [patent_app_date] => 2007-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11170 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11946303 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6574430 [patent_doc_number] => 20100129354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'INTRANASAL DELIVERY OF POLYPEPTIDES AND PROTEINS' [patent_app_type] => utility [patent_app_number] => 12/312121 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 24620 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129354.pdf [firstpage_image] =>[orig_patent_app_number] => 12312121 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751946 [patent_doc_number] => 20080160019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'SEQUENTIAL COMBINATION THERAPY' [patent_app_type] => utility [patent_app_number] => 11/873856 [patent_app_country] => US [patent_app_date] => 2007-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 22088 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160019.pdf [firstpage_image] =>[orig_patent_app_number] => 11873856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4751907 [patent_doc_number] => 20080159980 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'Combination cancer therapy with a GST-activated anticancer compound and another anticancer therapy' [patent_app_type] => utility [patent_app_number] => 11/872659 [patent_app_country] => US [patent_app_date] => 2007-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8480 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0159/20080159980.pdf [firstpage_image] =>[orig_patent_app_number] => 11872659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5585482 [patent_doc_number] => 20090104684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-23 [patent_title] => 'Diagnosis of carcinomas' [patent_app_type] => utility [patent_app_number] => 11/890896 [patent_app_country] => US [patent_app_date] => 2007-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 21119 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20090104684.pdf [firstpage_image] =>[orig_patent_app_number] => 11890896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5574900 [patent_doc_number] => 20090142261 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-04 [patent_title] => 'EPHB3-Specific Antibody and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 11/833726 [patent_app_country] => US [patent_app_date] => 2007-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 43592 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20090142261.pdf [firstpage_image] =>[orig_patent_app_number] => 11833726 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4745357 [patent_doc_number] => 20080089959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Composition and uses of galectin antagonists' [patent_app_type] => utility [patent_app_number] => 11/803150 [patent_app_country] => US [patent_app_date] => 2007-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10976 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20080089959.pdf [firstpage_image] =>[orig_patent_app_number] => 11803150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6262519 [patent_doc_number] => 20100297110 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'ANTIBODY SPECIFIC FOR HUMAN IL-4 FOR THE TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 12/293781 [patent_app_country] => US [patent_app_date] => 2007-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 2629 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0297/20100297110.pdf [firstpage_image] =>[orig_patent_app_number] => 12293781 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5538712 [patent_doc_number] => 20090220517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'METHOD FOR PRODUCING EPITOMERS AND THEIR USES ON CARRIER MICROORGANISMS' [patent_app_type] => utility [patent_app_number] => 12/162804 [patent_app_country] => US [patent_app_date] => 2006-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6445 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220517.pdf [firstpage_image] =>[orig_patent_app_number] => 12162804 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5330155 [patent_doc_number] => 20090110632 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-30 [patent_title] => 'BIOLOGICAL MATERIALS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/067905 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 12417 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20090110632.pdf [firstpage_image] =>[orig_patent_app_number] => 12067905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5041369 [patent_doc_number] => 20070093651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Ligand' [patent_app_type] => utility [patent_app_number] => 11/501522 [patent_app_country] => US [patent_app_date] => 2006-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 48537 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0093/20070093651.pdf [firstpage_image] =>[orig_patent_app_number] => 11501522 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10045221 [patent_doc_number] => 09085609 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-07-21 [patent_title] => 'Production of motif-specific and context-independent antibodies using peptide libraries as antigens' [patent_app_type] => utility [patent_app_number] => 11/484485 [patent_app_country] => US [patent_app_date] => 2006-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 38 [patent_no_of_words] => 25131 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11484485 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5171327 [patent_doc_number] => 20070071758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'CEACAM1 Based Cancer Therapy and Diagnosis' [patent_app_type] => utility [patent_app_number] => 11/423386 [patent_app_country] => US [patent_app_date] => 2006-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4937 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0071/20070071758.pdf [firstpage_image] =>[orig_patent_app_number] => 11423386 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5410051 [patent_doc_number] => 20090123950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => 'Generation And Profiling Of Fully Human Hucal Gold®-Derived Therapeutic Antibodies Specific For Human CD38' [patent_app_type] => utility [patent_app_number] => 11/920830 [patent_app_country] => US [patent_app_date] => 2006-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 19417 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20090123950.pdf [firstpage_image] =>[orig_patent_app_number] => 11920830 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4959679 [patent_doc_number] => 20080274104 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Targeting a Secreted Pro-Apoptotic Factor for Cancer Therapeutics' [patent_app_type] => utility [patent_app_number] => 11/816011 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 40500 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274104.pdf [firstpage_image] =>[orig_patent_app_number] => 11816011 [rel_patent_id] =>[rel_patent_doc_number] =>)